BioCentury | Mar 5, 2019
Financial News

Secura Bio closes $145M financing

...held executive positions at Prometheus Laboratories Inc., which was acquired by Nestlé S.A. (SIX:NESN), and Sequus Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Clinical News

Sequus preclinical data

...difference in survival rates was statistically significant for Amphotec compared to Abelcet and amphotericin B. Sequus Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Company News

Sequus, Bayer deal

...the blood stream undetected by the immune system. SEQU can receive R&D milestones and royalties. Sequus Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Company News

Mimetix Inc. management update

...Calif. Business: Neurological Hired: Donald Stewart as CFO; formerly VP of finance and treasurer at Sequus Pharmaceuticals Inc. WIR...
BioCentury | Feb 12, 2009
Tools & Techniques

PLAying with liposomes

...a cofounder of Sequus Pharmaceuticals Inc. , which developed Doxil doxorubicin, a liposomal cancer drug. In 1999, Sequus...
BioCentury | Oct 30, 2006
Company News

Athenagen management update

...Grove as VP of development operations, formerly VP of regulatory affairs at Johnson & Johnson's Sequus Pharmaceuticals Inc....
BioCentury | Dec 6, 2004
Product Development

Accelerated approval history

...cytarabine liposomal Lymphomatous meningitis 4/1/99 SkyePharma 1 (33) Doxil doxorubicin liposomal AIDS-related Kaposi's sarcoma 11/17/95 Sequus...
...now part of Johnson & Johnson) 1 (77) Doxil doxorubicin liposomal Metastatic ovarian carcinoma 6/28/99 Sequus...
BioCentury | Aug 11, 2003
Regulation

A little less ODAC

...chaired the committee from 1990 to 1992. Henderson later served as chairman and CEO of Sequus Pharmaceuticals Inc....
BioCentury | Dec 9, 2002
Company News

Targacept board of directors update

...general partner of New Enterprise Associates; and John Richard, former EVP of business development at Sequus...
BioCentury | Sep 30, 2002
Product Development

Cancer accelerated approvals

...Cancer accelerated approvals Product Company Indication Date approved Endpoint for accelerated approval Doxil liposomal doxorubicin Sequus...
Items per page:
1 - 10 of 171
BioCentury | Mar 5, 2019
Financial News

Secura Bio closes $145M financing

...held executive positions at Prometheus Laboratories Inc., which was acquired by Nestlé S.A. (SIX:NESN), and Sequus Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Clinical News

Sequus preclinical data

...difference in survival rates was statistically significant for Amphotec compared to Abelcet and amphotericin B. Sequus Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Company News

Sequus, Bayer deal

...the blood stream undetected by the immune system. SEQU can receive R&D milestones and royalties. Sequus Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Company News

Mimetix Inc. management update

...Calif. Business: Neurological Hired: Donald Stewart as CFO; formerly VP of finance and treasurer at Sequus Pharmaceuticals Inc. WIR...
BioCentury | Feb 12, 2009
Tools & Techniques

PLAying with liposomes

...a cofounder of Sequus Pharmaceuticals Inc. , which developed Doxil doxorubicin, a liposomal cancer drug. In 1999, Sequus...
BioCentury | Oct 30, 2006
Company News

Athenagen management update

...Grove as VP of development operations, formerly VP of regulatory affairs at Johnson & Johnson's Sequus Pharmaceuticals Inc....
BioCentury | Dec 6, 2004
Product Development

Accelerated approval history

...cytarabine liposomal Lymphomatous meningitis 4/1/99 SkyePharma 1 (33) Doxil doxorubicin liposomal AIDS-related Kaposi's sarcoma 11/17/95 Sequus...
...now part of Johnson & Johnson) 1 (77) Doxil doxorubicin liposomal Metastatic ovarian carcinoma 6/28/99 Sequus...
BioCentury | Aug 11, 2003
Regulation

A little less ODAC

...chaired the committee from 1990 to 1992. Henderson later served as chairman and CEO of Sequus Pharmaceuticals Inc....
BioCentury | Dec 9, 2002
Company News

Targacept board of directors update

...general partner of New Enterprise Associates; and John Richard, former EVP of business development at Sequus...
BioCentury | Sep 30, 2002
Product Development

Cancer accelerated approvals

...Cancer accelerated approvals Product Company Indication Date approved Endpoint for accelerated approval Doxil liposomal doxorubicin Sequus...
Items per page:
1 - 10 of 171